PL3272745T3 - Podstawione imidazolilem pochodne indolu wiążące receptor serotoninowy 5-HT7 oraz ich kompozycje farmaceutyczne - Google Patents
Podstawione imidazolilem pochodne indolu wiążące receptor serotoninowy 5-HT7 oraz ich kompozycje farmaceutyczneInfo
- Publication number
- PL3272745T3 PL3272745T3 PL16461543T PL16461543T PL3272745T3 PL 3272745 T3 PL3272745 T3 PL 3272745T3 PL 16461543 T PL16461543 T PL 16461543T PL 16461543 T PL16461543 T PL 16461543T PL 3272745 T3 PL3272745 T3 PL 3272745T3
- Authority
- PL
- Poland
- Prior art keywords
- imidazolyl
- pharmaceutical compositions
- serotonin receptor
- indole derivatives
- substituted indole
- Prior art date
Links
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 title 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title 1
- -1 Imidazolyl-substituted indole Chemical class 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16461543.7A EP3272745B1 (en) | 2016-07-21 | 2016-07-21 | Imidazolyl-substituted indole derivatives binding 5-ht7 serotonin receptor and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3272745T3 true PL3272745T3 (pl) | 2020-01-31 |
Family
ID=56507560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16461543T PL3272745T3 (pl) | 2016-07-21 | 2016-07-21 | Podstawione imidazolilem pochodne indolu wiążące receptor serotoninowy 5-HT7 oraz ich kompozycje farmaceutyczne |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10844046B2 (pl) |
| EP (1) | EP3272745B1 (pl) |
| CN (1) | CN109641877B (pl) |
| AU (1) | AU2017300841B2 (pl) |
| CA (1) | CA3031006A1 (pl) |
| DK (1) | DK3272745T3 (pl) |
| ES (1) | ES2744720T3 (pl) |
| HR (1) | HRP20191532T1 (pl) |
| HU (1) | HUE045355T2 (pl) |
| PL (1) | PL3272745T3 (pl) |
| PT (1) | PT3272745T (pl) |
| WO (1) | WO2018015558A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11572354B2 (en) | 2018-01-10 | 2023-02-07 | University Health Network | Inhibitor of indoleamine 2,3-dioxygenase-1 and methods of manufacture and use thereof |
| CN112174937B (zh) * | 2020-10-19 | 2022-06-03 | 南京农业大学 | 3-(5-咪唑基)吲哚类化合物及其制备方法和应用 |
| US20230391786A1 (en) * | 2022-06-02 | 2023-12-07 | Eli Lilly And Company | cGAS INHIBITORS |
| PL447976A1 (pl) * | 2024-03-11 | 2025-09-15 | Celon Pharma Spółka Akcyjna | Pochodna imidazolo-indolowa wiążąca się z receptorem serotoninowym 5-HT7, kompozycja farmaceutyczna zawierająca tę pochodną, zastosowania pochodnej i kompozycji oraz produkt pośredni do wytwarzania pochodnej imidazolo-indolowej |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| DE19948417A1 (de) | 1999-10-07 | 2001-04-19 | Morphochem Ag | Imidazol-Derivate und ihre Verwendung als Arzneimittel |
| US6281356B1 (en) * | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| EP2142535A2 (en) * | 2007-03-29 | 2010-01-13 | Novartis Ag | 3-imidazolyl-indoles for the treatment of proliferative diseases |
-
2016
- 2016-07-21 PL PL16461543T patent/PL3272745T3/pl unknown
- 2016-07-21 PT PT16461543T patent/PT3272745T/pt unknown
- 2016-07-21 DK DK16461543.7T patent/DK3272745T3/da active
- 2016-07-21 ES ES16461543T patent/ES2744720T3/es active Active
- 2016-07-21 EP EP16461543.7A patent/EP3272745B1/en active Active
- 2016-07-21 HU HUE16461543A patent/HUE045355T2/hu unknown
-
2017
- 2017-07-21 CA CA3031006A patent/CA3031006A1/en active Pending
- 2017-07-21 US US16/318,794 patent/US10844046B2/en not_active Expired - Fee Related
- 2017-07-21 AU AU2017300841A patent/AU2017300841B2/en not_active Ceased
- 2017-07-21 CN CN201780051323.5A patent/CN109641877B/zh not_active Expired - Fee Related
- 2017-07-21 WO PCT/EP2017/068531 patent/WO2018015558A1/en not_active Ceased
-
2019
- 2019-08-27 HR HRP20191532 patent/HRP20191532T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2744720T3 (es) | 2020-02-26 |
| PT3272745T (pt) | 2019-09-27 |
| AU2017300841A1 (en) | 2019-01-31 |
| AU2017300841B2 (en) | 2021-09-09 |
| CN109641877B (zh) | 2021-09-21 |
| CA3031006A1 (en) | 2018-01-25 |
| EP3272745B1 (en) | 2019-06-26 |
| US10844046B2 (en) | 2020-11-24 |
| CN109641877A (zh) | 2019-04-16 |
| DK3272745T3 (da) | 2019-09-02 |
| EP3272745A1 (en) | 2018-01-24 |
| WO2018015558A1 (en) | 2018-01-25 |
| HUE045355T2 (hu) | 2019-12-30 |
| US20190284169A1 (en) | 2019-09-19 |
| HRP20191532T1 (hr) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282584B (en) | History of quinoline and pharmaceutical preparations containing them | |
| IL254124A0 (en) | New 3-indole-transformed histories, medicinal preparations and methods of use | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| SI3426348T1 (sl) | Derivat 3-dezoksi in njegovi farmacevtski sestavki | |
| ZA201906395B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| ZA201806482B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| ZA201907713B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| IL269657A (en) | Transduced indulin derivatives as inhibitors of dengue virus replication | |
| IL270726A (en) | Transduced indulin derivatives as inhibitors of dengue virus replication | |
| IL261943A (en) | Transformed indulin derivatives as inhibitors of dengue virus replication | |
| PL3412660T3 (pl) | Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutyczna | |
| PT3606511T (pt) | Composição farmacêutica compreendendo mesilato de lenvatinib | |
| IL249803B (en) | History of azafenil and pharmaceutical preparations containing them | |
| SI3625224T1 (sl) | N-substituirani indolni derivati | |
| IL249308A0 (en) | The history of quinoline, their preparation and pharmaceutical preparations containing them | |
| IL248773B (en) | History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them | |
| HUE045355T2 (hu) | Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik | |
| IL258977B (en) | Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them | |
| PL3157506T3 (pl) | Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku | |
| PL3288933T3 (pl) | Związki oksindolowe i ich kompozycje farmaceutyczne | |
| PT3390403T (pt) | Composição farmacêutica compreendendo derivados de indole, processo para preparação e uso dos mesmos | |
| ZA201908398B (en) | N-substituted indole derivatives | |
| AP2016009517A0 (en) | Indole derivatives for use in medicine |